Equities
Health CareMedical Equipment and Services
  • Price (USD)86.21
  • Today's Change1.47 / 1.73%
  • Shares traded6.53m
  • 1 Year change+10.00%
  • Beta0.8378
Data delayed at least 15 minutes, as of Nov 22 2024 21:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Medtronic PLC had little change in net income (from 3.76bn to 3.68bn) despite revenues that grew 3.64% from 31.23bn to 32.36bn.
Gross margin65.46%
Net profit margin13.10%
Operating margin16.39%
Return on assets4.80%
Return on equity8.58%
Return on investment5.47%
More ▼

Cash flow in USDView more

In 2024, cash reserves at Medtronic PLC fell by 259.00m. However, the company earned 6.79bn from its operations for a Cash Flow Margin of 20.97%. In addition the company used 2.37bn on investing activities and also paid 4.45bn in financing cash flows.
Cash flow per share5.32
Price/Cash flow per share15.61
Book value per share37.81
Tangible book value per share-3.97
More ▼

Balance sheet in USDView more

Medtronic PLC has a Debt to Total Capital ratio of 36.77%, a lower figure than the previous year's 46.13%.
Current ratio1.84
Quick ratio1.39
Total debt/total equity0.5841
Total debt/total capital0.3677
More ▼

Growth rates in USD

Year on year, growth in dividends per share increased 1.47% while earnings per share excluding extraordinary items fell by -1.99%. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is in-line with the industry average relative to its peers, while earnings per share growth is below the industry average.
Div yield(5 year avg)2.47%
Div growth rate (5 year)6.65%
Payout ratio (TTM)63.62%
EPS growth(5 years)-4.17
EPS (TTM) vs
TTM 1 year ago
6.44
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.